Bone Biologics Income Statement (2010-2025) | BBLG

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating items
Research & Development (Quarter)	0.05M	0.00M		0.03M	0.04M	0.02M	0.77M	0.76M	2.59M	2.30M	1.57M	0.45M	0.25M	0.35M	0.43M	1.10M	0.42M	0.19M	0.19M	0.26M
Wages, Salaries and Other (Quarter)													0.12M	0.12M	0.12M	0.21M	0.12M	0.12M	0.12M	0.28M
Selling, General & Administrative (Quarter)	0.14M	0.23M	0.23M	0.43M	0.65M	0.45M	0.45M	0.53M	0.56M	0.74M	0.51M	0.71M	0.66M	0.46M	0.52M	0.45M	0.61M	0.56M	0.53M	0.48M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)	0.18M	0.23M	0.23M	0.46M	0.69M	0.47M	1.22M	1.29M	3.15M	3.04M	2.08M	1.16M	0.90M	0.81M	0.95M	1.55M	1.04M	0.75M	0.72M	0.73M
Operating Income (Quarter)	-0.18M	-0.23M	-0.23M	-0.46M	-0.69M	-0.47M	-1.22M	-1.29M	-3.15M	-3.04M	-2.08M	-1.16M	-0.90M	-0.81M	-0.95M	-1.55M	-1.04M	-0.75M	-0.72M	-0.73M
EBIT (Quarter)	-0.18M	-0.23M	-0.23M	-0.46M	-0.69M	-0.47M	-1.22M	-1.29M	-3.15M	-3.04M	-2.08M	-1.16M	-0.90M	-0.81M	-0.95M	-1.55M	-1.04M	-0.75M	-0.72M	-0.73M
Non-operating items
Interest & Investment Income (Quarter)										428.00	536.00	349.00	255.00	0.02M	0.02M	0.02M	0.02M	0.01M	0.05M	0.05M
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)									-0.56M	1.27M	0.16M	-0.39M	0.04M	0.03M	0.01M	0.03M	0.02M	0.01M	0.05M	0.09M
Net income details
EBT (Quarter)	-0.43M	-0.49M	-0.51M	-0.18M	-0.66M	-0.47M	-1.22M	-1.29M	-3.15M	-3.04M	-2.08M	-1.16M	-0.90M	-0.79M	-0.93M	-1.53M	-1.02M	-0.74M	-0.67M	-0.69M
Tax Provisions (Quarter)					0.03M	-0.03M
Profit After Tax (Quarter)	-0.43M	-0.49M	-0.51M	-0.18M	-0.69M	-0.47M	-1.22M	0.89M	-3.71M	-1.77M	-1.92M	-1.55M	-0.87M	-0.78M	-0.94M	-1.52M	-1.02M	-0.74M	-0.67M	-0.68M
Income from Continuing Operations (Quarter)	-0.43M	-0.49M	-0.51M	-0.18M	-0.69M	-0.44M	-1.22M	-1.29M	-3.15M	-3.04M	-2.08M	-1.16M	-0.90M	-0.79M	-0.93M	-1.53M	-1.02M	-0.74M	-0.67M	-0.69M
Consolidated Net Income (Quarter)	-0.43M	-0.49M	-0.51M	-0.18M	-0.69M	-0.44M	-1.22M	-1.29M	-3.15M	-3.04M	-2.08M	-1.16M	-0.90M	-0.79M	-0.93M	-1.53M	-1.02M	-0.74M	-0.67M	-0.69M
Income towards Parent Company (Quarter)	-0.43M	-0.49M	-0.51M	-0.18M	-0.69M	-0.44M	-1.22M	-1.29M	-3.15M	-3.04M	-2.08M	-1.16M	-0.90M	-0.79M	-0.93M	-1.53M	-1.02M	-0.74M	-0.67M	-0.69M
Net Income towards Common Stockholders (Quarter)	-0.43M	-0.49M	-0.51M	-0.18M	-0.69M	-0.44M	-1.22M	-1.29M	-3.15M	-3.04M	-1.92M	-1.55M	-0.90M	-0.79M	-4.15M	-1.52M	-1.02M	-0.74M	-0.67M	-0.68M
Additional items
EPS (Basic) (Quarter)	-0.15	-0.17	-0.17	0.14	-0.07	-1.36	-3.53	-24.26	-55.20	-5.21	-4.90	3.39	-1.31	-4.02	-14.21	0.13	-0.32	-1.33	-0.37	-0.14
EPS (Weighted Average and Diluted) (Quarter)						-1.36	-3.53	-24.26	-55.20	-5.21	-4.90	3.39	-1.31	-4.02	-14.21	0.13	-0.32	-1.33	-0.37	-0.14
Shares Outstanding (Weighted Average) (Quarter)	0.01M	2.91M	2.91M	4.54M	10.35M	0.35M	0.35M	0.05M	0.07M	0.30M	0.20M	0.26M	0.66M	0.19M	0.29M	0.25M	3.18M	0.54M	1.80M	1.17M
Shares Outstanding (Diluted Average) (Quarter)						0.35M	0.35M	0.05M	0.07M	0.34M	0.20M	0.26M	0.66M	0.15M	0.29M	0.25M	3.18M	0.56M	1.80M	1.17M
EBITDA (Quarter)	-0.18M	-0.23M	-0.23M	-0.46M	-0.69M	-0.47M	-1.22M	-1.29M	-3.15M	-3.04M	-2.08M	-1.16M	-0.90M	-0.81M	-0.95M	-1.55M	-1.04M	-0.75M	-0.72M	-0.73M
Interest Expenses (Quarter)	0.25M	0.26M	0.28M	0.01M
Shares Outstanding (Quarter)	12.27M	12.27M	12.27M	0.04M	10.35M	10.35M	10.35M	0.06M	0.07M	0.39M	0.39M	0.09M	0.17M	0.22M	0.35M	0.49M	0.55M	1.69M	1.80M	1.80M
Tax Rate (Quarter)					-5.04	6.71

Research Tools

Developers

Bone Biologics Income Statement (2010-2025) | BBLG

Research Tools

Developers

Bone Biologics Income Statement (2010-2025) | BBLG

Create an account

Sign In

Reset Password